FIBRYGA subst sèche 1 g c solv (nextaro)
7680668360031
CH-66836
B02BB01
06.01.1.
Reimbursement limitations:
BLUTPRODUKTE
Calcul des prix des préparations sanguines sur la base du prix « ex factory », …
1 / 3
google
Details
- Product number
- 6683602
- CPT
- -
- Packaging group
- -
- Unit
- 1 Durchstechflasche mit Pulver und 1 Durchstechflasche mit Lösungsmittel und Nextaro-Transfersystem
- Composition
- Praeparatio cryodesiccata: fibrinogenum humanum 1 g, natrii chloridum, natrii citras dihydricus, glycinum, arginini hydrochloridum pro vitro corresp. natrium 132 mg. Solvens: aqua ad iniectabile, pro vitro.
Articles (1)
Fibryga 1g, Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung
Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
1.0 G | Substance | Wirkstoff (Principe actif) |
|
SOLV
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
132.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 459.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2019
Authorization holder
Octapharma AG
8853 Lachen SZ
Authorization information
- Swissmedic authorization number
- 66836
- Drug name
- Fibryga, Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung
- Galenic form
- PULMK
- ATC Code
- B02BB01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 22/11/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 06.01.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- FIBRYGA subst sèche 1 g c solv (nextaro)
- Description (DE)
- FIBRYGA Trockensub 1 g c Solv (nextaro)
- Market launch
- 13/11/2020
- Narcotic (BTM)
- No